# Eurocell plc (ECEL.L) fundamentals

Data as of 2026-09-08. LSE, United Kingdom. Sector: Industrials / Building Products. Price 124p, market value 122 millionp.

## Valuation
- **P/E (trailing): 24.7×** (5-yr avg 1358.8×, 3-yr avg 1554.2×). Eurocell plc trades at 24.7× trailing earnings, well below its own five-year average of 1358.8×: cheap by its own standards. The Industrials median in the September 2026 study was 25.7×. Forward P/E is 5.9×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 0.2×**. Each dollar of revenue is priced at 0.2×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.2×**. The shares trade at 1.2× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 2.7×**. Enterprise value is 2.7× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 56.0%** (5-yr avg 0.2%). Free cash flow equals 56.0% of the market value, above its five-year average of 0.2%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 4.0%**. The inverse of the P/E: 4.0% of the price is earned each year.

## Profitability
- **Gross margin: 51.4%**. Eurocell plc keeps 51.4% of revenue after the direct cost of what it sells.
- **Operating margin: 5.6%**. 5.6% of revenue is left after running the business.
- **Net margin: 2.4%**. 2.4% of each dollar of sales reaches the bottom line.
- **Return on equity: 9.2%**. 9.2% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 16.2%**. Return on all capital, debt included, is 16.2%: comfortably above what that capital costs.
- **Return on assets: 7.0%**. Each dollar of assets produces 7.0% of profit.

## Growth
- **Revenue growth (1 yr): 12.7%** (3-yr 1.9%/yr, 5-yr 9.4%/yr). Revenue grew 12.7% over the last year, against 9.4% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): -3.2%** (3-yr -17.8%/yr). Earnings per share fell 3.2%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): 16.7%/yr**. Free cash flow has compounded at 16.7% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.99**. Debt is 0.99 times equity, moderate leverage.
- **Net debt / EBITDA: 1.2×**. It would take 1.2 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: 5.4×**. Operating profit covers interest 5.4× over, a safe margin.
- **Current ratio: 1.53** (quick 0.80). Current assets cover the next year's liabilities 1.53 times.
- **Altman Z-score: 2.75**. A Z-score of 2.75 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 5.30%** (0p per share, trailing). Eurocell plc yields 5.30%, an income-level yield.
- **Payout ratio: 65%** (18% of free cash flow). 65% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 1**. 1 straight year of increases.
- **Shareholder yield: 22.1%**. Dividends plus net buybacks return 22.1% of the market value a year.

## Price and momentum
- **Total return (1 yr): -4.6%** (YTD -6.5%, 3-mo 18.4%). The shares are down 4.6% over twelve months including dividends.
- **From 52-week high: -12.1%** (24.7% above the low). Trading 12% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 54**. An RSI of 54 is neutral.
- **Beta (1 yr): 0.35** (volatility 38%). Beta of 0.35 against the FTSE All-Share: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ECEL.L · Page: https://foliofundamentals.com/stocks/ecel.l

Not investment advice.